MAX BRANDON LUDLUM

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant WILMINGTON, NC NPI 1669918223

General Payments — all program years on this page

$3,704.57

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 225
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $662.55 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $662.5539

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $292.5021
Braeburn Inc. $84.905
Gilead Sciences, Inc. $84.734
Acerta Pharma LLC $59.953
USWM, LLC $40.821
Otsuka America Pharmaceutical, Inc. $25.081
Alkermes, Inc. $22.021
ITI, Inc. $20.711
Corium, Inc. $17.391
Novo Nordisk AS $14.451

By program year

Program yearAmountRecords
2021 $750.1851
2022 $1,240.8279
2023 $1,051.0256
2024 $662.5539

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100105931 Corium, LLC $17.39 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100329542 Novo Nordisk Inc $14.45 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104578356 AstraZeneca Pharmaceuticals LP $20.71 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105402023 AstraZeneca Pharmaceuticals LP $22.83 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105506030 AstraZeneca Pharmaceuticals LP $16.41 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563730 ABBVIE INC. $21.61 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563732 ABBVIE INC. $23.11 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563734 ABBVIE INC. $7.46 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563736 ABBVIE INC. $6.44 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563738 ABBVIE INC. $19.76 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563740 ABBVIE INC. $3.59 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563742 ABBVIE INC. $14.61 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563744 ABBVIE INC. $22.33 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563746 ABBVIE INC. $13.94 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563748 ABBVIE INC. $21.80 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563750 ABBVIE INC. $3.15 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563752 ABBVIE INC. $10.26 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563754 ABBVIE INC. $20.07 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563756 ABBVIE INC. $10.64 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563758 ABBVIE INC. $5.46 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563760 ABBVIE INC. $19.47 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563762 ABBVIE INC. $9.05 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563764 ABBVIE INC. $7.17 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563766 ABBVIE INC. $5.97 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563768 ABBVIE INC. $27.63 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107563770 ABBVIE INC. $18.98 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119125838 Otsuka America Pharmaceutical, Inc. $25.08 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120544624 Alkermes, Inc. $22.02 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125618742 Braeburn Inc. $16.71 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125618744 Braeburn Inc. $18.23 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125618746 Braeburn Inc. $14.96 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125618748 Braeburn Inc. $16.30 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125618750 Braeburn Inc. $18.70 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133715579 Gilead Sciences, Inc. $14.95 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133715581 Gilead Sciences, Inc. $23.47 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133715583 Gilead Sciences, Inc. $25.52 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133715585 Gilead Sciences, Inc. $20.79 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143536745 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.71 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152822315 USWM, LLC $40.82 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.